Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
1.660
+0.070 (4.40%)
At close: Nov 20, 2026, 4:00 PM EST
1.630
-0.030 (-1.81%)
After-hours: Nov 20, 2026, 7:49 PM EST
Alaunos Therapeutics Revenue
Alaunos Therapeutics had revenue of $3.00K in the twelve months ending September 30, 2026, down -50.00% year-over-year. In the year 2025, Alaunos Therapeutics had annual revenue of $5.00K, down -50.00%. That makes Alaunos Therapeutics the 47,571st largest company in the world by revenue and 7,268th in the United States.
Revenue (ttm)
$3.00K
Revenue Growth
-50.00%
P/S Ratio
2,328.63
Revenue / Employee
$3,000
Employees
1
Market Cap
6.99M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.00K | -5.00K | -50.00% |
| Dec 31, 2024 | 10.00K | 5.00K | 100.00% |
| Dec 31, 2023 | 5.00K | -2.92M | -99.83% |
| Dec 31, 2022 | 2.92M | 2.52M | 634.17% |
| Dec 31, 2021 | 398.00K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | 146.00K | -6.24M | -97.71% |
| Dec 31, 2017 | 6.39M | -472.00K | -6.88% |
| Dec 31, 2016 | 6.86M | 2.53M | 58.38% |
| Dec 31, 2015 | 4.33M | 2.96M | 215.51% |
| Dec 31, 2014 | 1.37M | 573.00K | 71.63% |
| Dec 31, 2013 | 800.00K | - | - |
| Dec 31, 2012 | 800.00K | 133.00K | 19.94% |
| Dec 31, 2011 | 667.00K | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Xenetic Biosciences | 2.96M |
| Traws Pharma | 2.73M |
| Curis | 1.14M |
| Can-Fite BioPharma | 405.00K |
| VivoSim Labs | 135.00K |
| AIM ImmunoTech | 91.00K |
| Silo Pharma | 36.05K |
| Creative Medical Technology Holdings | 3.00K |
TCRT News
- 5 days ago - Alaunos Therapeutics Transcript: UBS Global Biopharma Conference 2026 - Transcripts
- 6 days ago - Alaunos Therapeutics Quarterly report: Q3 2026 - Filings
- 9 days ago - Alaunos Therapeutics Registration statement: Registration filing - Filings
- 9 days ago - Alaunos Therapeutics Proxy statement: Proxy filing - Filings
- 9 days ago - Alaunos Therapeutics registers to sell 382.09M shares of common for holders - TheFly
- 9 days ago - Alaunos Therapeutics initiated with a Buy at TD Cowen - TheFly
- 11 days ago - Alaunos Therapeutics Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Alaunos Therapeutics announces completion of Velaris acquisition - TheFly